A Systematic Review and a Report of the 1st Clinical Trial in Egypt of the Use of Pegylated Interferon in HCV-Infected Cancer Survivors
Rania Gamil Ibrahim;
Abstract
HCV infection is a major health problem worldwide and Egypt has possibly the highest prevalence worldwide . HCV is considered a silent deadly epidemic as the majority of infected patients do not know they are infected and about 15-20% of them may develop
Other data
| Title | A Systematic Review and a Report of the 1st Clinical Trial in Egypt of the Use of Pegylated Interferon in HCV-Infected Cancer Survivors | Authors | Rania Gamil Ibrahim | Keywords | A Systematic Review and a Report of the 1st Clinical Trial in Egypt of the Use of Pegylated Interferon in HCV-Infected Cancer Survivors | Issue Date | 2008 | Description | HCV infection is a major health problem worldwide and Egypt has possibly the highest prevalence worldwide . HCV is considered a silent deadly epidemic as the majority of infected patients do not know they are infected and about 15-20% of them may develop |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.